IGC Pharma Inc. (IGC)
NYSE · Healthcare
IGC Pharma Inc. EPS 2011–2025
IGC Pharma Inc. annual/quarterly eps history and growth rate from 2011 to 2026. Earnings per share (EPS) is a company's net profit divided by the number of diluted shares outstanding. Higher EPS generally indicates greater profitability.
- IGC Pharma Inc. eps for the quarter ending March 31, 2026 was $0.02, a 0.00% increase year-over-year.
- IGC Pharma Inc. annual eps for 2025 was $0.09, a 59.09% decrease from 2024.
- IGC Pharma Inc. annual eps for 2024 was $0.22, a 214.29% increase from 2017.
- IGC Pharma Inc. annual eps for 2017 was $0.07, a 58.82% decrease from 2016.
- IGC Pharma Inc. annual eps for 2016 was $0.17.
EPS
ANNUAL · USD
QUARTERLY · USD
YEAR-OVER-YEAR GROWTH · %
IGC Pharma Inc. EPS — FAQ
IGC Pharma Inc. (IGC) eps over the last 15 years — annual and quarterly figures with year-over-year growth and charts.
What is IGC Pharma Inc.'s eps?
IGC Pharma Inc. (IGC) reported eps of $-0.09 for fiscal 2025.
Where can I see IGC's eps history?
The chart and table above show IGC Pharma Inc.'s eps by year and by quarter, including the growth rate.